2176485-21-3: 4,4′-Dichloro-3-(3-ethoxybenzyl)-3′-(4-ethoxybenzyl)-1,1′-biphenyl
4,4′-Dichloro-3-(3-ethoxybenzyl)-3′-(4-ethoxybenzyl)-1,1′-biphenyl CAS No: 2176485-21-3 is an impurity of Dapagliflozin which is utilized along with diet and exercise, and sometimes with other medications, to lower blood sugar levels in adults with type 2 diabetes. It belongs to a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors which lowers blood sugar by causing the kidneys to eliminate more glucose in the urine.
Additional information on CAS 2176485-21-3
Catalogue No.
VE008721
CAS No.
2176485-21-3
Molecular Formula
C30H28Cl2O2
Molecular Weight
491.45 g/mol
Parent drug
Dapagliflozin
IUPAC Name
4, 4'-Dichloro-3-(3-ethoxybenzyl)-3'-(4-ethoxybenzyl)-1, 1'-biphenyl
Synonyms
N/A
References
“Dapagliflozin: MedlinePlus Drug Information.” Medlineplus.gov, Feb. 2022, medlineplus.gov/druginfo/meds/a614015.html.
Status
In-stock
